Brand/generic to Indication Flashcards

1
Q

Lotensin (benazepril)

4

A

1: Hypertension
2: Heart Failure (OLU)
3: Diabetic nephropathy (OLU)
4: Kidney disease (OLU)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Capoten (captopril)

4

A

1: Hypertension
2: Congestive Heart Failure
3: Kidney problems caused by diabetes
4: Improved survival after a heart attack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Vasotec (enalapril)

4

A

1: Heart Failure
2: Hypertension
3: Kidney disease, nondiabetic
4: Diabetic nephropathy (OLU)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Monopril (fosinopril)

2

A

1: Heart Failure
2: Hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Prinivil, Zestril (lisinopril)

3

A

1: Acute myocardial infarction
2: Heart Failure
3: Hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Accupril (quinapril)

3

A

1: Heart Failure
2: Hypertension
3: Diabetic nephropathy (OLU)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Altace (ramipril)

5

A

1: Heart failure post MI
2: Hypertension
3: Reduced risk MI/stroke/death from CV cause
4: Diabetic nephropathy (OLU)
5: Kidney disease (OLU)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Atacand (candesartan)

2

A

1: Heart Failure
2: Hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Avapro (irbesartan)

4

A

1: Diabetic nephropathy in pts w/T2DM & HTN
2: Hypertension
3: Left ventricular hypertrophy (OLU)
4: Hypertension, renal impairment (OLU)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cozaar (losartan)

6

A

1: Hypertension
2: Heart Failure
3: Reduced risk of CVA in HTN-sive pts w/LVH, prophylaxis
4: Diabetic nephropathy
5: CV event risk reduction (OLU)
6: Isolated systolic hypertension, LV hypertension (OLU)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Benicar (olmesartan)

1

A

1: Hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diovan (valsartan)

3

A

1: Heart failure
2: Hypertension
3: MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Amoxil (amoxicillin)

8

A

1: Acute otitis media
2: Lower respiratory tract infection
3: Pharyngitis, tonsillitis
4: Streptococcal pharyngitis
5: Ear, nose, and throat infection
6: Helicobacter pylorigastrointestinal tract infection
7: Bacterial endocarditis, prophylaxis (OLU)
8: Lyme disease (OLU)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Augmentin (amoxicillin/clavulanate)

5

A

1: Acute otitis media
2: Community acquired pneumonia
3: Lower respiratory tract infection
4: Sinusitis, infection of skin or subcutaneous tissue, infectious disease of genitourinary system
5: Streptococcal pharyngitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Vibramycin (doxycycline)

5

A

1: Acinetobacter infection
2: Acne vulgaris
3: Gonorrhea, uncomplicated
4: Staphylococcal infection of skin
5: Lyme disease, prophylaxis (OLU)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

V-Cillin-K (Penicillin)

4

A

1: Bacterial endocarditis, prophylaxis in patients with congenital heart disease or rheumatic/acquired valvular heart disease
2: Otitis media
3: Streptococcal pharyngitis
4: Pneumococcal infectious disease, prophylaxis in patients with sickle cell disease or asplenia (OLU)

17
Q

Plavix (clopidogrel)

3

A

1: Acute ST and non–ST segment elevation myocardial infarction
2: Thrombosis prevention in arteriosclerotic vascular disease, following stroke, in peripheral arterial occlusive diseas
3: Thrombosis prevention in atrial fibrillation or following percutaneous coronary intervention (OLU)

18
Q

Pradaxa (dabigatran)

3

A

1: Treatment and prevention of initial or recurrent deep venous thrombosis and pulmonary embolism
2: Prevention of stroke and systemic embolism in patient with nonvalvular atrial fibrillation
3: Prevention of thromboembolism after orthopedic surgery (OLU)

19
Q

Coumadin (warfarin)

5

A

Multiple FDA-labeled indications, all dosed similarly, including:

1: Atrial fibrillation
2: myocardial infarction, post MI
3: prosthetic cardiac valve component embolism
4: pulmonary embolism; thrombosis, venous thromboembolism
5: Prevention of transient ischemic attacks